FDA Inspection 1020495 — StemImmune, Inc
The FDA completed an inspection of StemImmune, Inc on Aug 4, 2017 in San Diego, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Aug 4, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- San Diego, CA (United States)